2-[(3,5-dibromo-2-pyridinyl)iminomethyl]-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazole-4-carbonitrile
C19H11Br2N5O — CID 135438305
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(3,5-dibromo-2-pyridinyl)iminomethyl]-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazole-4-carbonitrile
2-[(3,5-dibromo-2-pyridinyl)iminomethyl]-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazole-4-carbonitrile (PubChem CID 135438305) has the molecular formula C19H11Br2N5O and a molecular weight of 485.14 g/mol. Its IUPAC name is 2-[(3,5-dibromo-2-pyridinyl)iminomethyl]-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazole-4-carbonitrile.
Molecular Properties
| Compound Name | 2-[(3,5-dibromo-2-pyridinyl)iminomethyl]-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazole-4-carbonitrile |
|---|---|
| PubChem CID | 135438305 |
| Molecular Formula | C19H11Br2N5O |
| Molecular Weight | 485.14 g/mol |
| Exact Mass | 482.93 |
| IUPAC Name | 2-[(3,5-dibromo-2-pyridinyl)iminomethyl]-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazole-4-carbonitrile |
| SMILES | Cc1c(C=Nc2ncc(Br)cc2Br)c(=O)n2c([nH]c3ccccc32)c1C#N |
| InChI | InChI=1S/C19H11Br2N5O/c1-10-12(7-22)18-25-15-4-2-3-5-16(15)26(18)19(27)13(10)9-24-17-14(21)6-11(20)8-23-17/h2-6,8-9,25H,1H3 |
| InChIKey | TYEFEACFCXDLRE-UHFFFAOYSA-N |
| XLogP | 4.63 |
| TPSA | 86.31 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 485.14 |
| LogP ≤ 5 | 4.63 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135438305 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.